Frederic Roch Doliveux
Président chez OXFORD BIOMEDICA PLC
Fortune : 1 M $ au 30/06/2024
Profil
Le Dr Frederic Roch Doliveux est président non exécutif d'Oxford Biomedica Plc, président du Caring Entrepreneurship Fund, président de Pierre Fabre SA et membre du Conseil international de l'INSEAD. Il est membre du conseil d'administration d'UCB SA, de la Vlerick Leuven Gent Management School, de Vlerick Research NV, de la Biotechnology Innovation Organization, de Pierre Fabre Participations SASU, du Science & Business Innovation Board et du Wallon Institute for Life Lead Sciences. Le Dr Doliveux a été précédemment employé en tant que président par GLG Healthcare Institute, directeur indépendant par Stryker Corp, directeur général et directeur exécutif par UCB SA, président par Schering-Plough Corp, président par Schering-Plough International, Inc, vice-président par European Federation of Pharmaceutical Industries & Assns, directeur général par Pierre Fabre Pharmaceuticals, Inc, et président par The Innovative Medicines Initiative. Il est titulaire d'un MBA de l'INSEAD et d'un doctorat de l'École Nationale Vtrinaire d'Alfort.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OXFORD BIOMEDICA PLC
0,35% | 20/09/2023 | 371 805 ( 0,35% ) | 1 M $ | 30/06/2024 |
Postes actifs de Frederic Roch Doliveux
| Sociétés | Poste | Début |
|---|---|---|
| OXFORD BIOMEDICA PLC | Président | 24/06/2020 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | - |
Vlerick Research NV
 Vlerick Research NV Miscellaneous Commercial ServicesCommercial Services Part of Vlerick Leuven Gent Management School, Vlerick Research NV provides research and development services. The company is based in Ghent, Belgium. The Belgian company was founded in 2001. Patrick de Greve has been the CEO of the company since 2008. | Directeur/Membre du Conseil | 01/11/2012 |
Pierre Fabre Participations SAS
 Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Pierre Fabre Participations SASU operates as a holding company, with interests in the manufacture of pharmaceutical products. The company is headquartered in Paris, France. | Directeur/Membre du Conseil | 24/07/2019 |
| Caring Entrepreneurship Fund | Président | 01/01/2009 |
| Vlerick Leuven Gent Management School | Directeur/Membre du Conseil | 01/10/2014 |
| Wallon Institute for Life Lead Sciences | Directeur/Membre du Conseil | 14/09/2010 |
| Science & Business Innovation Board | Directeur/Membre du Conseil | 14/09/2010 |
| INSEAD International Council | Corporate Officer/Principal | 15/03/2012 |
| ░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Frederic Roch Doliveux
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░ | - |
Formation de Frederic Roch Doliveux
| INSEAD | Masters Business Admin |
| École Nationale Vétérinaire d'Alfort | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| UCB | Health Technology |
| STRYKER CORPORATION | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| Entreprise privées | 15 |
|---|---|
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Commercial Services |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Retail Trade |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Pierre Fabre SA
 Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Health Technology |
| INSEAD International Council | |
| Science & Business Innovation Board | |
| Wallon Institute for Life Lead Sciences | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Schering-Plough International, Inc.
 Schering-Plough International, Inc. Pharmaceuticals: MajorHealth Technology Schering-Plough International, Inc. is a private company that manufactures and sells pharmaceuticals and health care products. The company is based in New Jersey, DE. | Health Technology |
| Caring Entrepreneurship Fund | |
GLG Healthcare Institute
 GLG Healthcare Institute Medical/Nursing ServicesHealth Services GLG Healthcare Institute provides healthcare services. The private company is based in New York. | Health Services |
Pierre Fabre Participations SAS
Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Pierre Fabre Participations SASU operates as a holding company, with interests in the manufacture of pharmaceutical products. The company is headquartered in Paris, France. | Health Technology |
| Pierre Fabre Pharmaceuticals, Inc. | |
Vlerick Research NV
Vlerick Research NV Miscellaneous Commercial ServicesCommercial Services Part of Vlerick Leuven Gent Management School, Vlerick Research NV provides research and development services. The company is based in Ghent, Belgium. The Belgian company was founded in 2001. Patrick de Greve has been the CEO of the company since 2008. | Commercial Services |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
